The Reliability and Validity of Perioperative Cognitive Test Network Platform for Monitoring Neurocognitive Changes
1 other identifier
observational
400
0 countries
N/A
Brief Summary
This study aimed to analyze the reliability and validity of the results of the new designed perioperative cognitive test network platform, and to judge the reliability and scientific nature of the perioperative cognitive test. And then to explore whether the perioperative cognitive test network platform can be used to evaluate the changes of perioperative cognitive function of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2023
CompletedFirst Posted
Study publicly available on registry
September 8, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedSeptember 14, 2023
June 1, 2023
3 months
July 7, 2023
September 13, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Reliability
Cronbach's alpha is used to assess the reliability and the internal consistency of this Cognitive test. Cronbach's alpha value \>0.7 indicating the reliability of the test is acceptable.
Baseline Test:1 day before operation, Second Test: Day 7 after operation
Validity
Content validity, Construct validity and Responsiveness analysis are used to evaluate the validity of the cognitive test. The item-content validity index (I-cvi) is used evaluate the Content validity. I-cvi≥ 0.78 means the content validity is satisfactory. The Exploratory Factor Analysis (EFA) is used evaluate the Construct validity. The Kaiser-Mayer-Olkin (KMO) index (\>0.6) is used to evaluate adaptability for factor analysis. Factor loading should \>0.4. The Responsiveness analysis is used to evaluate the ability of this cognitive test that can reflect the change of cognitive function of the Interviewer during operation. Paired t-test can be used to compare whether the difference in score before and after is statistically significant. P value should \< 0.05.
Baseline Test:1 day before operation, Second Test: Day 7 after operation
Secondary Outcomes (1)
PND (Perioperative neurocognitive disorders)
Baseline Test:1 day before operation, Second Test: Day 7 after operation
Study Arms (2)
Elderly patients undergoing surgery
Older than or equal to 65 years of age; patients who intend to undergo major abdominal surgery under general anesthesia (grade 3-4 surgery based on surgical grade)
Elderly healthy volunteers
Age-and sex-matched community population
Eligibility Criteria
This study will include two groups: elderly healthy volunteers and elderly patients undergoing abdominal surgery.
You may qualify if:
- Age over 65
- Scheduled for abdominal surgery under general anesthesia (grade 3-4 surgery based on surgical grade)
- Informed consent has been obtained
- Healthy volunteer groups are listed as age-and sex-matched community groups
You may not qualify if:
- Unable to follow instruction and finish the firtst procedure
- Has severe visual or auditory problems
- History of drug or alcohol abuse (drinking more than 5U daily in the past 3 months, 1U equals 10ml or 8g pure alcohol, equivalent to \>50 liquor over 100ml, two two
- Are diagnosed neuropsychological disease that needs treatment
- Clear history of severe cerebrovascular diseases (including cerebral hemorrhage and cerebral infarction), Parkinson's syndrome, schizophrenia, bipolar disorder, depression, dementia, Alzheimer's disease, etc
- Severe head trauma, carbon monoxide poisoning and other loss of consciousness more than 30 minutes
- MMSE score ≤23
- Participated this study or being participating other clinical research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2023
First Posted
September 8, 2023
Study Start
October 1, 2023
Primary Completion
December 31, 2023
Study Completion
March 31, 2024
Last Updated
September 14, 2023
Record last verified: 2023-06